ABSTRACT: Four cycloartane type triterpenoids and three stigmastane type steroids were isolated from the methanolic extract of stem and root part of Pothos scandens L. (Araceae), a Bangladeshi medicinal plant by high performance liquid chromatographic technique. The compounds were characterized as 24-methylenecycloartanol (1), 24-methylenecycloartenone (2), 24-en-cycloartenone (3), 24-methylenecycloartanyl ferulate (4), stigmast-4-en-3-one (5), stigmast-4,22-diene-3-one (6) and β-sitosterol glucoside (7) through extensive 1D and 2D NMR spectroscopic studies. All the isolates were evaluated for their estrogenic/antiestrogenic activity using the estrogen-responsive breast cancer cell lines, MCF-7 and T47D. The results showed that all the compounds possess mild to strong antiestrogenic activity in both cell lines which was compared to positive control tamoxifen. 24-Methylenecycloartanol (1), which contains a hydroxyl group in its C-3 position, inhibited 90% of estradiol (E2)-induced cell proliferation in MCF-7 and T47D cell lines at a concentration of 0.01 µM only. 24-Methylenecycloartanyl ferulate (4) and stigmast-4,22-diene-3-one (6) showed 90% of estradiol (E2)-induced cell proliferation in T47D cell only at a concentration of 0.01 µM whereas 10.0 µM was required for 24-methylenecycloartanyl ferulate (4) for the same activity in MCF-7 cells. This is the first report of isolation of these compounds from the plant along with their antiestrogenic property.
INTRODUCTION
17β-Estradiol (E 2 ), one of the primary circulating ovarian steroids, is predominantly responsible for the development and regulations of reproductive organs and secondary sex characteristics in female. The development of breast epithelium is mainly regulated by E 2 but excessive level of it may cause genesis of breast cancer.
1 During the menopause, the level of E 2 is markedly reduced. In response, aromatization of circulating androgens is facilitated causing excessive E 2 production, which increases the risk of breast estrogen inhibits the milk production in lactating mother. 5 In search of potential leads, several initiatives have been taken worldwide and some of the isolates like khainaoside A, terminalosides, pothobanosides, syringerasinol, principin showed antiestrogenic activity whereas biochanin, tectorigenin, genistein, dalparvins B, C etc. stimulated cell proliferation of estrogen-responsive breast cancer cells. [6] [7] [8] [9] [10] [11] As the majority of the Bangladeshi people are living under the poverty line, many of them tend to afford traditional medicines because of their easy availability, cheaper price, and little or no side effects. Among the 6000 plant species which are enlisted in national encyclopedia of Bangladesh, near about 1000 plant species are medicinally useful and have been documented. 12, 13 So far, few attempts have been taken for the scientific evidence of Bangladeshi medicinal plants which have estrogenic and/or antiestrogenic properties.
14 Pothos scandens L., belonging to a welldiversified family of Araceae, is a medicinal aroid commonly known as 'Batilata' in the tribal people of hill tracts region of Bangladesh. The whole plant is used in treating skin disorders, asthma, snake bite, diarrhoea, cancer, small pox, sprains, epilepsy, convulsions and wound. [14] [15] [16] [17] The leaves of the plant is used to induce conception in women in certain part of India such as Tamilnadu. [18] [19] Previous phytochemical investigations resulted the isolation of pothobanoside A-C, dodecanoic acid, tetradecanoic acid, phytol, markhamiosides, flavone-di-glycosides, methyl pothoscandensate, N-trans-cinnamoyltyramine, N-trans-feruloyltyramine, serotobenine and syringeresinol etc. 10 The present study deals with the extraction and isolation of bioactive secondary metabolites followed by structure elucidations using spectroscopic methods. Estrogenic and/or antiestrogenic properties were also investigated using two different cell lines, MCF-7 and T47D.
MATERIALS AND METHODS

General experimental procedures.
1 H NMR (500 MHz), 13 ; Methanolic wash part) was subjected to semi-preparative HPLC with Inertsil C8-3 column (five times injected) using MeCN-H 2 O (97.5:2.5) as mobile phase to afford 7 fractions. From these subfractions, fraction F-19-5 (27.5 mg; t R 46 min) was again subjected to semi-preparative HPLC with YMC ODS column using MeCN-H 2 O (97.5:2.5) as mobile phase to afford 24-methylenecycloartenone (2) (10.1 mg; t R 145 min) and 24-methylenecycloartanol (1) (1.5 mg; t R 178 min). Similarly, fraction F-19-4 (44.8 mg; t R 37 min) was subjected to semi-preparative HPLC with YMC ODS column using MeCN-H 2 O (97.5:2.5) as mobile phase to provide 24-encycloartenone (3) (3.8 mg; t R 128 min), stigmast-4,22-dien-3-one (6) (1.8 mg; t R 140 min) and stigmast-4-en-3-one (5) From the combined fractions, fraction K (0.7 g), eluted with chloroform-MeOH (9:1) gradient solvent system, was dissolved in MeOH. This led to precipitation of β-sitosterol glucoside (71) (43.3 mg; white crystals) which was further purified through recrystallization.
Cell proliferation assay. MCF-7 and T47D human breast cancer cells were purchased from the American Type Culture Collection (Manassas, VA) and cultured. The estrogenic activity (cell proliferation assay) was performed by the protocol described in the previous report. 10 Alamar blue reagent was used to determine the cell concentrations and fluorescence were measured at 590 nm with excitation at 530 nm using a Wallac 1420 ARVOsx multilabel counter (Perkin-Elmer Inc., Wellesley, MA).
Antiestrogenic assay. The antiestrogenic assay was performed according to the procedure described previously. 6 MCF-7 and T47D cells were seeded at a density of (1.0-1.2) x 10 4 cells/well in 96-well plates in 90 µL of 5% DCC-treated, FBS-supplemented RPMI phenol red-free medium. After 3 h incubation, 5 µL of each test compounds at four different concentrations of ranging 0.01 to 10 µM was added to each well together with 5 µL of estradiol (E 2 ) at a concentration of 20 nM to make final volume 100 µL in each well. Finally, the plates were incubated in a CO 2 incubator for 96 h. Then 5 µL of serially diluted tamoxifen at concentrations ranging from 0.01 to 10 µM, was used as positive control. The result was calculated from the cell populations, and iEqE values of each sample (iEqE 50 , iEqE 10 and iEqE 1 ) were determined for the required concentrations to inhibit the E 2 effect (iEqE 50 ; iEqE 10 ; and iEqE 1 , the concentration suppressing the E 2 effect to the equivalent level of 50; 10; and 1 pM, respectively). When samples suppressed E 2 activity to the level less than 10 or 50 pM through the concentrations tested, they were categorized as strong (s) or mild (M), respectively.
RESULTS AND DISCUSSION
Isolation and structure identification. The crude methanolic extract of stem and root part of P. scandens was subjected to partitioning process between EtOAc and H 2 O to get solid mass.
Preliminary estrogenic activity screenings with EtOAc soluble fractionate showed moderate inhibitory estrogenic effects in different cell lines at a concentration of 0.2 µg/mL. In continuation with the results, EtOAc soluble fractionate was subjected to silica gel column chromatography and purified by HPLC to yield 7 nonpolar compounds. Compound 2, obtained as a white amorphous powder, showed very much similar NMR spectra (Table 1) to that of compound 1. However, instead of an oxymethine signal at C-3 position in 1, a carbonyl group resonance at δ C 216.6 appeared in the 13 C NMR spectrum. Thus, the structure of 2 was identified as 24-methylenecycloartenone by comparing with published values. 21, 22 Compound 3 was also obtained as a white amorphous powder. The NMR spectra (Table 1) showed very much similarity with those of 2. Instead of exomethylene protons signals in C-24 positions in the compound 2, an olefinic proton signal [δ 5.10 (1H, td, J = 5.5, 1.0 Hz, H-24) appeared in 3, suggesting that the difference was occurred in position C-24. In accordance with the published literatures, 3 was identified as 24-en-cycloartenone. 23 Compound 4 was obtained as white amorphous powder and showed characteristic 24-methylenecycloartane type triterpenoid resonances in its NMR spectra (Table 3) (5) and stigmast-4, 22-dien-3-one (6) in literatures. [25] [26] [27] Compound 7 was obtained as a white amorphous powder and it showed similar NMR spectra appropriate for stigmastane type skeleton. 
28
Estrogenic/antiestrogenic activity. Literature survey revealed that leaf extract of P. scandens is used to induce conception. In order to prove this traditional use, a cell based screening was conducted to determine whether the isolates possess any of the estrogenic/antiestrogenic properties using estradiol (E 2 ) responsive ATCC breast cancer cells (MCF-7 and T47D). While estradiol (E 2 ) displayed significant cell proliferation activity in a dose dependent manner (1 to 100 pM), none of the isolates showed estrogen like activity at a concentration of 0.01 to 10 µM (data not shown). Therefore, there is no scientific basis that this plant could be used to induce conception. Antiestrogenic activities were also investigated for all the isolates. The breast cancer cells (MCF-7 and T47D) proliferation was induced initially by using 100 pM of estradiol (E 2 ). These cells were cotreated with the each isolates at four different concentrations at 0.01, 0.1, 1.0 and 10.0 µM (Table  4) . In order to compare with a positive control, estrogen receptor antagonist (tamoxifen) was used in this assay which suppressed the E 2 -enhanced cell proliferation nearly completely (iEqE 1 ) at the concentration of lower than 9.0 µM in both cells. All compounds showed at least 50% inhibition in both cell lines at the lowest tested concentration (Table 4) . Among the cycloartane type triterpenoids, 90% inhibition (iEqE 10 ) of cell proliferation (induced by 100 pM of estradiol) in T47D and MCF-7 cells were occurred with 24-methylenecycloartanol (1) at a concentration of lower than 0.01 µM. On the other hand, 24-methylenecycloartanyl ferulate (4) displayed 90% inhibition of cell proliferations (induced by 100 pM of estradiol) in T47D cells only at a concentration of 0.01 µM. Both of the compounds possess either free hydroxyl group or feruloyl moiety attached to oxygen of a hydroxyl group in C-3 position in their structures. Part of the chemical structure is similar as quinona-methide triterpenes tingenone and pristimerin which showed antiestrogenic or cytotoxic activities presenting IC 50 value 2 and 5 µM, respectively. 29 Due to possible hydrogen bonding with estrogen receptors, these two compounds showed antiestrogenic activity. 30 24-Encycloartenone (3) suppressed 90% cell proliferation (induced by 100 pM of estradiol) in T47D cells at a concentration less than 0.1 µM. Ninety percent cell proliferation (induced by 100 pM of estradiol) in T47D cells was observed with stigmast-4,22-dien-3-one (5) at a concentration less than 0.01 µM whereas in case of MCF-7 cells, the required concentration could not be tested.
Previous study suggested that high levels of estrogen may increase the risk of breast cancer in postmenopausal women. 31 Therefore, compounds 1 and 4 may have the potential as lead compounds for further drug developments. However, detailed studies are required to establish their efficacy in human being.
CONCLUSION
Extensive phytochemical investigation of EtOAc soluble materials of the methanolic extracts of P. scandens has revealed seven known cycloartane and stigmastane type triterpenoids (1) (2) (3) (4) (5) (6) (7) . All the isolates were tested for their estrogenic and/or antiestrogenic properties using two different cell lines. All of them showed at least 50% inhibition of estradiol induced cell proliferation. Among them, compound 1 inhibited the cell growth by up to 90% in both cell lines whereas 4 and 6 inhibited 90% the cell growth in T47D cells only. 
